Imagine you are a small biotech with an exciting asset with promising early phase clinical results. This bodes well for […]
“All improvement happens project by project and in no other way” – Joseph M Juran There is something in that, […]
Effective patient recruitment can accelerate the commercialization of new medicines more than any other single optimization. Unfortunately, patient recruitment is […]
Regulatory Target Product Profiles (RTPPs) RTPPs describe the aims of a drug development programme in terms of labelling concepts. They can be used […]
Emerging TPPs As a drug moves through development its properties, activity and effect on disease are revealed. ETPPs are used […]
Aspirational Target Product Profiles (ATPPs) ATPPs provide the context for and set targets along a range of key criteria that are required to […]
Target Product Profiles (TPPs) are descriptions of key features needed in a new treatment for a disease and are used to […]
The interest in drug repurposing has grown, as the effort required to bring new drugs to market has increased. When […]
Developing orphan drugs is a risky business. Small numbers of patients, despite high prices, may not lead to high revenue […]
Consequences for Medical Devices in case of a no deal Brexit. Over the Counter (OTC) remedies may not seem like […]